# AstraZeneca Pharmaceuticals LP - Inspection Records

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b

> Inspection records and compliance data for AstraZeneca Pharmaceuticals LP in Philadelphia, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: AstraZeneca Pharmaceuticals LP
- FEI Number: 3004829714
- City: Philadelphia
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 3001 Red Lion Rd
- Zip Code: 19114

## Related Documents

- [CRL - AstraZeneca Pharmaceuticals LP - Unknown Date](https://www.keypedia.com/records/crl/astrazeneca-pharmaceuticals-lp/f522475b-222d-454f-bb23-a7910b73b215) — source: FDA, date: Invalid Date
- [FDA Inspection 1277181 - AstraZeneca Pharmaceuticals LP - 2025-06-24](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/1a98a255-d819-49e6-b7de-cd49b86deb31) — source: FDA, date: June 24, 2025
- [FDA Inspection 1277181 - AstraZeneca Pharmaceuticals LP - 2025-06-24](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/e43ee0f7-c3c7-47da-8b35-cbd2bc20ba46) — classification: No Action Indicated (NAI), source: FDA, date: June 24, 2025
- [483 - AstraZeneca Pharmaceuticals LP - 2022-07-22](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/cbeb85bf-3ed5-456e-9ea8-d27f7367f0b1) — source: FDA, date: July 22, 2022
- [FDA Inspection 1175133 - AstraZeneca Pharmaceuticals LP - 2022-07-22](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/dae5e2be-5942-4a41-b4a5-3f7bf88d2245) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2022
- [FDA Inspection 1060670 - AstraZeneca Pharmaceuticals LP - 2018-06-20](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/500df3a2-86d2-4a61-9aca-64742d4d4bf0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2018
- [FDA Inspection 940375 - AstraZeneca Pharmaceuticals LP - 2015-05-20](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/bffe3385-7575-4247-815a-dd280b7172e5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2015
- [FDA Inspection 846805 - AstraZeneca Pharmaceuticals LP - 2013-05-22](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/c22f62c3-cfee-4e9e-9f25-b0b365a29274) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2013
- [FDA Inspection 747381 - AstraZeneca Pharmaceuticals LP - 2011-05-03](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/6ef05072-7e87-49c5-b502-be7527582ef6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2011
- [FDA Inspection 671182 - AstraZeneca Pharmaceuticals LP - 2010-06-23](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/11493b37-191a-4fe6-9b02-a0d607b0491e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 23, 2010
- [FDA Inspection 635722 - AstraZeneca Pharmaceuticals LP - 2009-12-07](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/916e88b4-8ef6-48c2-be06-e2f334f1fdb4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2009
- [FDA Inspection 601426 - AstraZeneca Pharmaceuticals LP - 2009-06-16](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/bc5d904d-a3aa-4c0c-8f66-ceb8716194cb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2009

## Related Companies

- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)
- [Finish Line Horse Products, Inc.](https://www.keypedia.com/companies/finish-line-horse-products-inc/205e6869-8995-4e35-9af4-e022b2dedb77)
- [Fareva Richmond, Inc.](https://www.keypedia.com/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb)
- [Janssen Pharmaceuticals Inc.](https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623)
- [Amgen Technology (Ireland) Unlimited Company](https://www.keypedia.com/companies/amgen-technology-ireland-unlimited-company/576ab93b-ec8d-4b76-b25c-a1c473d6ae61)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Glaukos Corporation](https://www.keypedia.com/companies/glaukos-corporation/9e9a7fd4-2158-4073-b5b9-79ba4fbdde83)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/b3d7bba7-bfc8-4d2b-a517-321f7b518a12)
- [Reckitt Benckiser Healthcare Manufacturing (Thailand) Ltd.](https://www.keypedia.com/companies/reckitt-benckiser-healthcare-manufacturing-thailand-ltd/016a0f4a-a4f3-47c7-8efa-58dc8165038d)
- [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.](https://www.keypedia.com/companies/octapharma-pharmazeutika-produktionsgesellschaft-mbh/36184852-dad7-4350-8b6f-36d4527ba46f)

## Related Officers

- [Investigator](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)
- [Mohammed Al-Qasmi](https://www.keypedia.com/people/mohammed-al-qasmi/8324cc78-bb12-4cc0-b74d-35a8e8585f44)